Paper. Rucker JJ, Mantingh T, Kerr-Gaffney J et al.. Nature Medicine, 6 Aug 2026.
Tags: Human, RCT, Psilocybin, Depression.
60 people with treatment-resistant depression received a single 25 mg dose of psilocybin or a placebo, both with preparation and integration support. At week 3, depression scores were about 10 points lower with psilocybin, and the difference held at week 6. 59 of 60 people completed every follow-up.
How much weight it carries: Randomized and double-blind, but small and designed as a feasibility trial. The authors call for a larger confirmatory trial. (Humans, RCT, n = 60, Peer reviewed)